Supplementary Figure S6 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
Year: 2026
Type: supplementary-materials
Abstract: Cell cycle and signaling changes induced by treatment with VIC-1911 and adavosertib in parental, AfaR, and ErlR HNSCC models.
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7202351016
Cites:
Cited by:
Related to: